PPARγ-IN-2 is a PPARγ inhibitor that suppresses triglyceride (TG) accumulation in 3T3-L1 preadipocytes (EC50: 0.106 μM); it inhibits high-fat cholesterol (HFC) diet-induced obesity and associated metabolic syndrome, and reduces lipid accumulation in adipose tissue.